Antiplatelet therapy for Reduction of MYocardial Damage during Angioplasty 4 - ARMYDA-4

Description:

The goal of the trial was to compare the efficacy and safety of a 600 mg clopidogrel loading dose with placebo among patients undergoing percutaneous coronary intervention (PCI) who were on chronic clopidogrel therapy.